None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participant in either intervention or control group of the Small Babies Trial Child aged 24 months (?29 days) at enrollment Family intends to remain in study area for next 3 years Written informed consent from parent/caregiver
Exclusion criteria
Exclusion criteria: Any chronic diagnosed condition which impairs growth Diagnosed and documented neurodevelopmental impairment currently receiving specialized therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Linear Growth: Height-for-age z-score (HAZ) Neurodevelopment: IQ, Executive function, School readiness assessed using standardized toolsTimepoint: 5 years 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolic Health: Biomarkers (HOMA-IR, lipid profile, HbA1c, CRP, IL-6, adiponectin, leptin. HaemoglobinTimepoint: 5 years;Anthropometry (Wt, ht; head, waist ? circumference, MUAC)Timepoint: Every 6 months starting from 2 years;Morbidity & care-seekingTimepoint: Every 6 months starting from 2 years;Dietary intake/diversity (subsample)Timepoint: Baseline, 3, 4 & 5 years;Parental EmpowermentTimepoint: Baseline and 5 years;Body Composition (DXA)Timepoint: 5 years;Non-alcoholic fatty liver disease: Abdominal ultrasoundTimepoint: 5 years;Physical activityTimepoint: Baseline, 5 years | — |
Countries
India
Contacts
Society for Applied Studies